(C) Common Dreams
This story was originally published by Common Dreams and is unaltered.
. . . . . . . . . .
Costs and underuse of insulin and diabetes supplies: Findings from the 2020 T1International cross-sectional web-based survey [1]
[]
Date: 2021-09-01
63.2% of participants reported disruption of insulin supplies and 25.3% reported an increase of insulin prices related to the COVID-19 pandemic.
Worldwide, one out of every four respondents reported having underused their insulin at least once within the last year due to high cost.
This study is the most extensive patient-led out-of-pocket cost survey for people living with type 1 diabetes.
Abstract
Aims To investigate self-reported out-of-pocket expenses (OoPE) associated with insulin and diabetes supplies for people living with type 1 diabetes (T1D) worldwide.
Methods A web-based, cross-sectional survey was conducted from August to December 2020. The analysis included comparisons between responses from countries with no, partial, and full healthcare coverage.
Results 1,066 participants from 64 countries took part in the study. ~25% of respondents reported having underused insulin at least once within the last year due to perceived cost. A significant correlation was observed between OoPEs and reported household income for respondents with partial healthcare coverage. 63.2% of participants reported disruption of insulin supplies and 25.3% reported an increase of prices related to the COVID-19 pandemic.
[END]
---
[1] Url:
https://www.sciencedirect.com/science/article/pii/S0168822721003557
Published and (C) by Common Dreams
Content appears here under this condition or license: Creative Commons CC BY-NC-ND 3.0..
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/commondreams/
